Education
About Us
Working with TipRanks
Follow Us
Quantum-Si (QSI)
NASDAQ:QSI
QSI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.61 - $5.77
Previous CloseN/A
Volume35.47M
Average Volume (3M)6.15M
Market Cap
$242.99M
Enterprise Value$156.84M
Total Cash (Recent Filing)$214.21M
Total Debt (Recent Filing)$11.14M
Price to Earnings (P/E)―
Beta2.59
Next Earnings
Nov 05, 2025EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding182,557,700
10 Day Avg. Volume4,244,197
30 Day Avg. Volume6,149,791
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.65
Enterprise Value/Revenue45.97
Enterprise Value/Gross Profit86.46
Enterprise Value/Ebitda-1.47
Forecast
1Y Price Target
$2.50Price Target Upside111.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
International GrowthThe company reported that ex-US revenues made up nearly 85% of the total revenues for 1Q25, indicating strong international growth potential.
PartnershipsThe company's partnership with Avantor is viewed as a tailwind to sales in the biopharma sector.
Product DevelopmentQSI's new kit improves sequencing coverage with the addition of glycine recognition, enhanced alanine and serine recognition, an enzyme designed to cut through the amino acid directly proceeding proline and new algorithms to benefit precision and mixture handling.
Bears Say
Financial PerformanceManagement reported markedly lower revenue than the consensus expectation, attributing it partially to NIH funding challenges and a shift towards biopharmaceutical companies with longer sales cycles.
Macroeconomic ConditionsThe company's recent financial performance has been negatively affected by macroeconomic headwinds.
Revenue ExpectationsThe company reported total revenues of $808K, lower than consensus estimated revenue of $960K for 1Q25.
Quantum-Si News
QSI FAQ
What was Quantum-Si’s price range in the past 12 months?
Quantum-Si lowest stock price was $0.61 and its highest was $5.77 in the past 12 months.
What is Quantum-Si’s market cap?
Quantum-Si’s market cap is $242.99M.
When is Quantum-Si’s upcoming earnings report date?
Quantum-Si’s upcoming earnings report date is Nov 05, 2025 which is in 52 days.
How were Quantum-Si’s earnings last quarter?
Quantum-Si released its earnings results on Aug 05, 2025. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.143 by -$0.017.
Is Quantum-Si overvalued?
According to Wall Street analysts Quantum-Si’s price is currently Undervalued.
Does Quantum-Si pay dividends?
Quantum-Si does not currently pay dividends.
What is Quantum-Si’s EPS estimate?
Quantum-Si’s EPS estimate is -0.13.
How many shares outstanding does Quantum-Si have?
Quantum-Si has 182,557,700 shares outstanding.
What happened to Quantum-Si’s price movement after its last earnings report?
Quantum-Si reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.143. Following the earnings report the stock price went down -4.861%.
Which hedge fund is a major shareholder of Quantum-Si?
Currently, no hedge funds are holding shares in QSI
Quantum-Si Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.50 (111.86% Upside)
$2.50 (111.86% Upside)
Blogger Sentiment
Neutral
QSI Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 752.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $106.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 4.0%
Last 30 Days ▼ 4.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
30.96%
12-Months-Change
Fundamentals
Return on Equity
-46.87%
Trailing 12-Months
Asset Growth
-0.91%
Trailing 12-Months
Company Description
Quantum-Si
Quantum-Si (QSI) is a biotechnology company focused on advancing the field of proteomics through its proprietary next-generation protein sequencing technology. Operating primarily in the life sciences sector, Quantum-Si aims to unlock the potential of proteins to drive discoveries in drug development, diagnostics, and personalized medicine. The company's core product offerings include its protein sequencing platform and related software solutions, which enable researchers and clinicians to analyze protein structures and functions with unprecedented accuracy and speed.
QSI Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While there were significant advancements in product development and strategic initiatives to counteract capital sales challenges, revenue fell short of expectations due to NIH funding uncertainties. The company's strong cash position and innovation roadmap progress are positives, but the lack of financial guidance and increased operating expenses indicate ongoing challenges.View all QSI earnings summariesQSI Stock 12 Month Forecast
Average Price Target
$2.50
▲(111.86% Upside)
Technical Analysis
Nautilus Biotechnolgy
―
Foghorn Therapeutics
―
Atea Pharmaceuticals
―
Compass Therapeutics
―
Seer
―
Ownership Overview
23.17% Insiders
5.66% Mutual Funds
11.87% Other Institutional Investors
47.06% Public Companies and
Individual Investors